The landscape of metabolic management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatid and This Retatrutide represent significant advancements; Tirzepatid https://1226337.blog-center.com/61777920/tirzepatide-retatrutide-a-new-metabolic-duo